New Results
A synthetic lethal dependency on casein kinase 2 in response to replication-perturbing drugs in RB1-deficient ovarian and breast cancer cells
View ORCID ProfileDaria Bulanova, Yevhen Akimov, Wojciech Senkowski, Jaana Oikkonen, Laura Gall-Mas, Sanna Timonen, Manar Elmadani, Johanna Hynninen, View ORCID ProfileSampsa Hautaniemi, Tero Aittokallio, Krister Wennerberg
doi: https://doi.org/10.1101/2022.11.14.516369
Daria Bulanova
1Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark
2Institute for Molecular Medicine Finland, Helsinki Institute for Life Sciences, University of Helsinki, Helsinki, Finland
Yevhen Akimov
2Institute for Molecular Medicine Finland, Helsinki Institute for Life Sciences, University of Helsinki, Helsinki, Finland
Wojciech Senkowski
1Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark
Jaana Oikkonen
3Research Program in Systems Oncology (ONCOSYS), University of Helsinki, Helsinki, Finland
Laura Gall-Mas
1Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark
Sanna Timonen
2Institute for Molecular Medicine Finland, Helsinki Institute for Life Sciences, University of Helsinki, Helsinki, Finland
Manar Elmadani
4Finnish Red Cross Blood Service, Helsinki, Finland
Johanna Hynninen
5Department of Obstetrics and Gynecology, Turku University Hospital and University of Turku, Turku, Finland
Sampsa Hautaniemi
3Research Program in Systems Oncology (ONCOSYS), University of Helsinki, Helsinki, Finland
Tero Aittokallio
2Institute for Molecular Medicine Finland, Helsinki Institute for Life Sciences, University of Helsinki, Helsinki, Finland
6Institute for Cancer Research, Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway
7Oslo Centre for Biostatistics and Epidemiology (OCBE), University of Oslo, Oslo, Norway
Krister Wennerberg
1Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark

Article usage
Posted November 16, 2022.
A synthetic lethal dependency on casein kinase 2 in response to replication-perturbing drugs in RB1-deficient ovarian and breast cancer cells
Daria Bulanova, Yevhen Akimov, Wojciech Senkowski, Jaana Oikkonen, Laura Gall-Mas, Sanna Timonen, Manar Elmadani, Johanna Hynninen, Sampsa Hautaniemi, Tero Aittokallio, Krister Wennerberg
bioRxiv 2022.11.14.516369; doi: https://doi.org/10.1101/2022.11.14.516369
A synthetic lethal dependency on casein kinase 2 in response to replication-perturbing drugs in RB1-deficient ovarian and breast cancer cells
Daria Bulanova, Yevhen Akimov, Wojciech Senkowski, Jaana Oikkonen, Laura Gall-Mas, Sanna Timonen, Manar Elmadani, Johanna Hynninen, Sampsa Hautaniemi, Tero Aittokallio, Krister Wennerberg
bioRxiv 2022.11.14.516369; doi: https://doi.org/10.1101/2022.11.14.516369
Subject Area
Subject Areas
- Biochemistry (9556)
- Bioengineering (7071)
- Bioinformatics (24785)
- Biophysics (12575)
- Cancer Biology (9927)
- Cell Biology (14304)
- Clinical Trials (138)
- Developmental Biology (7934)
- Ecology (12083)
- Epidemiology (2067)
- Evolutionary Biology (15960)
- Genetics (10905)
- Genomics (14710)
- Immunology (9848)
- Microbiology (23591)
- Molecular Biology (9460)
- Neuroscience (50725)
- Paleontology (369)
- Pathology (1535)
- Pharmacology and Toxicology (2675)
- Physiology (4001)
- Plant Biology (8645)
- Synthetic Biology (2388)
- Systems Biology (6415)
- Zoology (1345)